Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Commitment to partnership and joint innovation for cell and gene therapies
C&EN, November 12, 2018
Irish Examiner, 21 june 2021
Executiva, 23 February 2026
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Hovione commitment to setting SBTs in line with the Paris Agreement
Spray drying has become one of the most successful particle engineering technologies for improving drug bioavailability through the amorphous solid dispersion platform.